Opendata, web and dolomites

HeatNMof SIGNED

Heating triggered drug release from nanometric inorganic-metal organic framework composites

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HeatNMof project word cloud

Explore the words cloud of the HeatNMof project. It provides you a very rough idea of what is the project "HeatNMof" about.

photo    release    routes    drawbacks    health    heating    bioavailability    domain    drug    sound    societal    porous    entities    either    triggered    prime    networking    although    soundly    platforms    interdisciplinary    academic    resonance    thermal    interaction    generation    reactions    therapy    toxicity    nanocarrier    consequently    insufficient    heatnmof    imaging    material    antitumoral    inside    improvement    characterization    inorganic    nanomaterials    demand    society    bench    hyperthermia    industrial    expertise    physicochemical    biocompatibility    training    biocompatible    revolutionize    magnetic    metal    hybrid    scientists    living    optoacoustic    excellent    releases    successful    nanotechnology    efficient    drugs    potent    nanomedicine    frameworks    administration    train    multifunctional    exceptional    body    nanometric    organic    environment    nanocarriers    materials    reproducibility    additional    platform    intersectorial    biological    versatile    nanoparticles    optimization    concerning    payloads    upcoming    matters    smart    cancer   

Project "HeatNMof" data sheet

The following table provides information about the project.

Coordinator
Fundacion IMDEA Energia 

Organization address
address: AVENIDA RAMON DE LA SAGRA 3
city: MOSTOLES MADRID
postcode: 28935
website: http://www.imdea.org/energia

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙139˙408 €
 EC max contribution 3˙139˙408 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Fundacion IMDEA Energia ES (MOSTOLES MADRID) coordinator 501˙809.00
2    FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA IT (GENOVA) participant 522˙999.00
3    IMMATERIAL LABS LTD UK (CAMBRIDGE) participant 303˙172.00
4    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) participant 274˙802.00
5    INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE FR (TOULOUSE) participant 274˙802.00
6    UNIVERSITEIT ANTWERPEN BE (ANTWERPEN) participant 256˙320.00
7    UNIVERSITAET HAMBURG DE (HAMBURG) participant 252˙788.00
8    ISERN PATENTES Y MARCAS M SL ES (MADRID) participant 250˙904.00
9    NANOSCALE BIOMAGNETICS SOCIEDAD LIMITADA ES (ZARAGOZA) participant 250˙904.00
10    UNIVERSIDAD DE SANTIAGO DE COMPOSTELA ES (SANTIAGO DE COMPOSTELA) participant 250˙904.00

Map

 Project objective

Although recent advances in nanotechnology have provided an excellent platform to revolutionize the domain of health, the efficient and target delivery of many potent drugs in the body still remains an important challenge due to important drawbacks either from the drug (bioavailability, toxicity, etc.) and/or from the nanocarrier (biocompatibility, reproducibility, insufficient targeting). Consequently, there is currently a real demand for drug nanocarriers able to solve these matters for the different administration routes. HeatNMof project aims to develop smart multifunctional nanocarriers of challenging antitumoral drugs based on versatile highly porous biocompatible nanometric Metal Organic Frameworks, associated with exceptional drug payloads and controlled releases, and photo- and/or magnetic inorganic nanoparticles, providing both a specific control of reactions inside living entities (i.e. heating-triggered drug release) and additional properties such as imaging (magnetic resonance, thermal or optoacoustic imaging) and/ or hyperthermia therapy. The successful development of this project, involving academic and industrial partners, will contribute to the improvement of the highly societal relevant cancer therapy. This research objective is strongly related with the prime training/networking aim of HeatNMof: to train the next generation of materials scientists in a highly interdisciplinary and intersectorial research environment, such that they can soundly address upcoming challenges concerning nanomedicine, from the development, optimization and (physicochemical and biological) characterization of inorganic and hybrid materials, as well as their interaction with living entities, with a strong focus on drug delivery platforms based on nanomaterials. HeatNMof will train the next generation of material scientists with sound expertise in nanomedicine, highly needed to bring advanced materials as proposed from the bench to society.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEATNMOF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEATNMOF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More